Prolactinomas: Neurosurgical aspects;Prolactinomas: Aspectos neurocirúrgicos

Arquivos de Neuro-Psiquiatria

Volumn 60, Issue 1, 2002, Pages 106-112

  Tella Jr , Oswaldo Inácio ^a   Herculano, Marco Antonio ^a   Delcello, Rosana ^a   Aguiar, Paulo Henrique ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adenomas; Amenorrhoea; Galactorrhea; Prolactinomas; Transsphenoidal

Indexed keywords

PROLACTIN; TUMOR PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CANCER STAGING; CHILD; FEMALE; HUMAN; HYPOPHYSIS TUMOR; MALE; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROLACTINOMA;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA;

EID: 0038966152     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2002000100019     Document Type: Article

References (35)

1. Frantz G, Likeinberg DL. Prolactin: evidence that it is separate from growth hormone in human blood. Science 1970;170:745-746.
2. Hwang P, Guyda H, Friesen H. A radio-imunoassay for human prolactin. Proc Natl Acad Sci (USA) 1971;68:1902-1906.
3. Arafah BM, Kailani S, Selman WR. Physiology and pathophysiology of prolactin secretion. In Barrow DL & Selman W (eds). Concepts in neurosurgery: neuroendocrinology. Vol 5. Baltimore: Williams & Wilkins, 1992:95-112.
4. Fine SA, Frohman LA. Loss of central nervous system component of dopaminergic inhibition of prolactin-secretion in patients with prolactin secreting pituitary tumors. J Clin Invest 1978;61:973-980.
5. Bression D, Brandi AM, Martes MP. Dopaminergic receptors in human prolactin-secreting adenomas: a quantitative study. J Clin Endocrinol Metab 1980;51:1037-1048.
6. Spada A, Nicosia S, Cortelazz L. In vitro studies on prolactin release and adenylate cyclase activity in human prolactin secreting adenomas: different sensitivity of macro and microadenomas to dopamine and vasoactive intestinal polypeptide. J Clin Endocrinol Metab 1983;56:1-10.
7. Molitch M. Pathogenesis of pituitary tumors. Endocrinol Metab Cl N Am 1987;16:503-527.
8. Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 1990;71:1427-1433.
9. Frankel RH, Tindall GT. Prolactinomas. In Krisht AL, Tindall GT (eds). Pituitary disorders. Baltimore: Lippincott Williams & Wilkins, 1999:199-208.
10. Spark RF, Baker R, Bienfang DC, Bergland R. Bromocriptine reduces pituitary tumor size and hypersecretion. JAMA 1982;247:311-316.
11. Dananberg J, Dalkin AC. Medical treatment of pituitary adenomas. In Lloyd RV (ed). Surgical pathology of the pituitary gland. 1.Ed. Philadelphia: W.B. Saunders Company, 1993:211-234.
12. Cunnah D, Besser M. Management of prolactinomas. Clin Endocrinol 1991;34:231-235.
13. Landolt AM, Osterwalder V. Perivascular fibrosis and prolactinomas: is it increased with bromocriptine. J Clin Endocrinol Metab 1984; 58:1179-1183.
14. Pernicone PJ, Scheithauer BW. Invasive pituitary adenomas and pituitary carcinomas. In Lloyd RV (ed). Surgical pathology of the pituitary gland. Philadelphia: W.B. Saunders, 1993:121-136.
15. Hsu DW, Raine J, Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 1981;75:734-738.
16. Delcello R. Adenomas hipofisários: aspectos histopatológicos e imunohistoquímicos. Tese, Escola Paulista de Medicina. São Paulo, 1994.
17. Wilson CB. Role of surgery in the management of pituitary tumors. In Rosenblum ML (ed). Neurosurgery clinics of North America. Vol 1. Philadelphia; W.B. Saunders, 1990:139-160.
18. Hardy J, Beauregard H, Robert F. Prolactin-secreting pituitary adenomas: transsphenoidal microsurgery treatment. Clin Neurosurg 1980; 27:38.
19. Massoud F, Serri O, Hardy J, Somma M, Beauregard H. Transsphenoidal adenomectomy for microprolactinomas: 10 to 20 years of follow-up. Surg Neurol, 1996;45:341-346.
20. Verlaat JW, Croughs RJM, Hendriks MJ, Bosma NJ. Results of primary treatment with bromocriptine of prolactinomas with extrasellar extension. Can J Neurol Sci 1990;17:71-73.
21. Thorner MO. Prolactinoma. In Bardin CW (ed). Current therapy in endocrinology and metabolism. Philadelphia: B.C. Decker, 1991:35-38.
22. Adams CBT. The management of pituitary tumors and post-operative visual deterioration. Acta Neurochir (Wien) 1988;94:103-116.
23. Couldwell WT, Simard MF, Weiss MH. Surgical management of growth hormone-secreting and prolactin-secreting pituitary adenomas. In Schmidek HH, William H (eds). Sweet operative neurosurgical techniques. 3.Ed. Philadelphia: W.B. Saunders, 1995:843-850.
24. Murphy FY, Vesely DL, Jordan RM, Flanigan S, Kohler PO. Giant invasive prolactinomas. Am J Med 1987;83:995-1002.
25. Witrack GA, Zlonis MS, Larson DM. A fatal invasive prolactin-producing pituitary adenoma causing hypoglossal nerve paresis. Arch Pathol Lab Med 1986;110:1188-1189.
26. Davis JRE, Shepard MC, Heath DA. Giant invasive prolactinoma: a case report and review of nine further cases. Q J Med 1990;275:227-238.
27. Popovic EA, Vattuone JR, Siu KH, Busmanis I, Pullar MJ, Dowling J. Malignant prolactinomas. Neurosurg 1991;29:127-130.
28. Cook RJ, Besser M. A 16 year old boy with poor vision and nasal obstruction. Aust N Z J Surg 1987;57:485-488.
29. Kocijancic A, Prezelj J, Vrhovec I, Lancranjan I. Parlodel LAR in the treatment of macroprolactinomas. Acta Endocrinol (Copenh) 1990;122: 272-276.
30. Bronstein MD, Musolino NR, Benabou S, Marino R Jr. Cerebrospinal fluid rhinorrhea occurring in long-term bromocriptine treatment for macroprolactinomas. Surg Neurol 1989;32:346-349.
31. Rush S, Donahue B, Cooper P, Lee C, Persky M, Newall J. Prolactin reduction after combined therapy for prolactin macroadenomas. Neurosurg 1991;28:502-505.
32. Landolt AM, Keller PJ, Froesch ER. Bromocriptine: does it jeopardize the result of later surgery for prolactinomas? Lancet 1982;2:657-658.
33. Sisam DA, Sheehan JP, Sheeler LR. The natural history of untreated microprolactinomas. Fertil Steril 1987;48:67-71.
34. Tella Jr OI. Adenomas hipofisários. Rev Neurociências 1995;3:71-75.
35. Wesley AK, Becker DP. The transsphenoidal approach to pituitary macroadenomas with cavernous sinus extensions. In AL-Mefty O, Origitano TC, Harkey HL (eds). Controversies in neurosurgery. New York: Thieme 1995:15-20.